EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Myostatin antisense administration prevents sepsis‐induced muscle atrophy and weakness in male mice

Nobuto Nakanishi iD, Kazuhiro Maeta, Yuko Ono, Takumi Hirabayashi, Daisuke Tatebayashi, Kensuke Nakamura, Shigeaki Inoue, Masafumi Matsuo, Joji Kotani

Physiological Reports · 2025

DOI: 10.14814/phy2.70566 ↗

At a glance

Journal article in Physiological Reports, 2025. Written by Nobuto Nakanishi and 8 co-authors. Institution: Division of Disaster and Emergency Medicine, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan. Major MEDLINE topics: Myostatin, Muscular Atrophy, Sepsis, Muscle Weakness. Cited 1 times so far (Crossref); 57 references. The full text is freely available (open access, CC BY 4.0). Funded by: Japan Society for the Promotion of Science London (JSPS).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Muscle atrophy and weakness are serious problems associated with sepsis. However, only a few pharmacological interventions are available to date. In this study, myostatin antisense was used to prevent sepsis‐induced muscle atrophy and weakness. Sepsis was induced in 8‐week‐old male C57BL/6J mice via intraperitoneal injection of 1 mg/g cecal slurry (CS). Myostatin antisense was injected into the right tibialis anterior muscle. Myostatin mRNA was measured in the tibialis anterior and quadriceps femoris muscles on Day 1. The body weight, grip strength, and cross‐sectional area of the tibialis anterior muscle were measured on Day 6. The administration of myostatin antisense decreased myostatin expression on Day 1 in the injected side (0.023 ± 0.010 in CS vs. 0.008 ± 0.002 in CS + antisense) as well as in the noninjected muscles. It also decreased the myostatin protein level (2.0 ± 0.3 in CS vs. 1.2 ± 0.5 in CS + antisense, p = 0.04). Body weight reduction (94.9% ± 2.0% vs. 98.2% ± 1.8%, p < 0.01) and grip strength reduction (77.0% ± 12.3%vs. 89.8% ± 8.3%, p = 0.04) were suppressed by the injection. The cross‐sectional area of the right tibialis anterior muscle increased after the treatment (1116 ± 530 μm 2 vs. 1435 ± 648 μm 2 , p < 0.01). Myostatin antisense suppressed the elevation of myostatin mRNA expression in whole muscles of mice with sepsis and prevented sepsis‐induced muscle atrophy and weakness.

Subjects

MeSH terms (MEDLINE)

MyostatinMuscular AtrophySepsisMuscle WeaknessOligonucleotides, AntisenseAnimalsMaleMice, Inbred C57BLMiceMuscle, Skeletal

Author keywords

antisenseatrophymusclemyostatinsepsis

Substances

MyostatinMstn protein, mouseOligonucleotides, Antisense

Authors and institutions

  • Division of Disaster and Emergency Medicine, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
  • Quality Assurance Section, Pharmaceutical Quality Assurance Dept., KNC Laboratories Co., Ltd., Izumo, Shimane, Japan.
  • Division of Rehabilitation Medicine, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Division of Rehabilitation, Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan.
  • Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama, Japan.
  • Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Hyogo, Japan.

ORCID profiles: Nobuto Nakanishi

Funding

  • Japan Society for the Promotion of Science London (JSPS)

Cite

APA

Nakanishi, N., Maeta, K., Ono, Y., Hirabayashi, T., Tatebayashi, D., Nakamura, K., Inoue, S., Matsuo, M., & Kotani, J. (2025). Myostatin antisense administration prevents sepsis‐induced muscle atrophy and weakness in male mice. Physiological Reports. https://doi.org/10.14814/phy2.70566

Vancouver

Nakanishi N, Maeta K, Ono Y, Hirabayashi T, Tatebayashi D, Nakamura K, et al. Myostatin antisense administration prevents sepsis‐induced muscle atrophy and weakness in male mice. Physiological Reports. 2025. doi:10.14814/phy2.70566

BibTeX
@article{Nakanishi2025,
  author = {Nakanishi, Nobuto and Maeta, Kazuhiro and Ono, Yuko and Hirabayashi, Takumi and Tatebayashi, Daisuke and Nakamura, Kensuke and Inoue, Shigeaki and Matsuo, Masafumi and Kotani, Joji},
  title = {Myostatin antisense administration prevents sepsis‐induced muscle atrophy and weakness in male mice},
  journal = {Physiological Reports},
  year = {2025},
  doi = {10.14814/phy2.70566}
}
Start for free →